Literature DB >> 34553252

Kidney complications in 107 Fanconi anemia patients submitted to hematopoietic cell transplantation.

Mariana Munhoz da Cunha1,2, Fellype Carvalho Barreto3, Samantha Nichele4, Joanna Trennepohl4, Lisandro Ribeiro4, Gisele Loth4,5, Adriana Koliski4, Tyane de Almeida Pinto Jardim6, Adriana Mello4,5, Ricardo Pasquini4, Lucimary de Castro Sylvestre7,8, Carmem Bonfim4,5.   

Abstract

Fanconi anemia (FA) is a rare disease characterized by progressive bone marrow failure, cancer predisposition, and multiple systemic malformations, including congenital abnormalities of the kidney and urinary tract (CAKUT). Hematopoietic cell transplantation (HCT), the only potentially curative treatment for the hematological complications of FA, may precipitate acute kidney injury (AKI) and hypertension. We retrospectively investigated 107 FA patients who underwent HCT between 2009 and 2017. We investigated the incidence and risk factors of AKI within 100 days after HCT in a cohort of FA patients, and kidney function and hypertension over 2-year follow-up.The incidence of AKI (mainly stage I) was 18.7%. Patients aged ≥ 11 years at transplantation showed a higher risk of AKI (OR 3.53). The eGFR was 60-90 mL/min/1.73 m2 in 53 (49.5%), 55 (51.4%), 50 (50.5%), 50 (51%), and 46 (59.7%) patients before HCT, at 100 days, 6 months, 1 year, and 2 years. Within the first 100 days after HCT, hypertension was observed in 72% of the patients and was associated with cyclosporine therapy. Most (62.3%) patients had stage 2 hypertension. CAKUT was observed in 33.7% of the patients and was associated with both hypertension (86%) and diminished kidney function but not with AKI.Conlusion: Although AKI, a commonly known HCT complication, was mild in this study, the prevalence of chronic kidney disease (CKD), as well as the high incidence of hypertension, specially associated with CAKUT point out the importance of kidney care in short and long-term follow up of FA patients. What is Known: • Fanconi anemia (FA) is the most frequent inherited bone marrow failure in children, and 30% of cases have congenital anomalies of kidney (CAKUT). • Acute kidney injury and hypertension after hematopoietic cell transplantation (HCT) may impact the outcomes.. What is New: • Despite the presence of CAKUT and stage 2 CKD in 33.7% and 50% of the patients, respectively, AKI was mild and transitory after HCT in FA patients. • CAKUT in FA patients was associated with lower kidney function and hypertension after HCT.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Acute kidney injury; CAKUT; Fanconi anemia; Hematopoietic cell transplantation; Hypertension

Mesh:

Year:  2021        PMID: 34553252     DOI: 10.1007/s00431-021-04263-0

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.860


  32 in total

Review 1.  Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations.

Authors:  Christen L Ebens; Margaret L MacMillan; John E Wagner
Journal:  Expert Rev Hematol       Date:  2016-12-21       Impact factor: 2.929

2.  The Fanconi Anemia Pathway in Cancer.

Authors:  Joshi Niraj; Anniina Färkkilä; Alan D D'Andrea
Journal:  Annu Rev Cancer Biol       Date:  2018-12-03

3.  Outcome of 69 allogeneic stem cell transplantations for Fanconi anemia using HLA-matched unrelated donors: a study on behalf of the European Group for Blood and Marrow Transplantation.

Authors:  P Guardiola; R Pasquini; I Dokal; J J Ortega; M van Weel-Sipman; J C Marsh; S E Ball; F Locatelli; C Vermylen; R Skinner; P Ljungman; R Miniero; P J Shaw; G Souillet; M Michallet; A N Bekassy; G Krivan; P Di Bartolomeo; C Heilmann; L Zanesco; J Y Cahn; W Arcese; A Bacigalupo; E Gluckman
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

4.  Results of Allogenic Hematopoietic Stem Cell Transplantation in Fanconi Anemia Caused by Bone Marrow Failure: Single-Regimen, Single-Center Experience of 14 Years.

Authors:  Gulen Tuysuz; Elif Guler; Deniz Ozel; Alphan Kupesiz
Journal:  Biol Blood Marrow Transplant       Date:  2019-06-11       Impact factor: 5.742

Review 5.  How I manage patients with Fanconi anaemia.

Authors:  Carlo Dufour
Journal:  Br J Haematol       Date:  2017-05-05       Impact factor: 6.998

6.  Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.

Authors:  Navneet S Majhail; Tejo R Challa; Daniel A Mulrooney; K Scott Baker; Linda J Burns
Journal:  Biol Blood Marrow Transplant       Date:  2009-09       Impact factor: 5.742

7.  Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.

Authors:  Paul A Hoffmeister; Sangeeta R Hingorani; Barry E Storer; K Scott Baker; Jean E Sanders
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-02       Impact factor: 5.742

8.  Long-term Survival, Organ Function, and Malignancy after Hematopoietic Stem Cell Transplantation for Fanconi Anemia.

Authors:  Carmem Bonfim; Lisandro Ribeiro; Samantha Nichele; Marco Bitencourt; Gisele Loth; Adriana Koliski; Vaneuza A M Funke; Daniela V Pilonetto; Noemi F Pereira; Mary E D Flowers; Eunike Velleuer; Ralf Dietrich; Anders Fasth; Cassius C Torres-Pereira; Paola Pedruzzi; Mary Eapen; Ricardo Pasquini
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-11       Impact factor: 5.742

9.  Incidence and risk factors for early-onset hypertension after allogeneic hematopoietic stem cell transplantation in children.

Authors:  Dae Hyun Kwon; Seungwon Jung; Eun-Jung Lee; Jae Young Lee; Sena Moon; Jae Wook Lee; Nack Gyun Chung; Bin Cho; Hack Ki Kim
Journal:  Korean Circ J       Date:  2013-12-20       Impact factor: 3.243

10.  Patterns and frequency of renal abnormalities in Fanconi anaemia: implications for long-term management.

Authors:  Vijaya Sathyanarayana; Beth Lee; Neville B Wright; Rui Santos; Denise Bonney; Robert Wynn; Leena Patel; Kate Chandler; Ed Cheesman; Detlev Schindler; Nicholas J A Webb; Stefan Meyer
Journal:  Pediatr Nephrol       Date:  2018-04-12       Impact factor: 3.714

View more
  1 in total

Review 1.  Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability.

Authors:  Moisés Ó Fiesco-Roa; Benilde García-de Teresa; Paula Leal-Anaya; Renée van 't Hek; Talia Wegman-Ostrosky; Sara Frías; Alfredo Rodríguez
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.